Chronic kidney disease (CKD) is an increasingly recognized burden for patients and health
care systems with high (and growing) global incidence and prevalence, significant mortality …

Chronic kidney disease (CKD) is an epidemic health issue that requires global attention [1].
The worldwide increment of CKD incidence is related to an increase in traditional risk factors …

Background: Discovery of the ideal biomarker for clinical care remains a major challenge.
Recent progress in genomic and proteomic technologies has allowed the identification of …

The World Health Organization has estimated mortality and burden of chronic kidney
disease (CKD) in 2002 and predicted it will rank 13th in 2030 instead of 17th in 2002 among …

Background Chronic kidney disease (CKD) is an increasingly significant health issue
worldwide. Early stages of CKD can be asymptomatic and disease trajectory difficult to …

The use of “omics” is increasing in research areas looking to identify biomarkers or early
preclinical signs of disease or to increase understanding of complex pathological processes …

Chronic kidney disease (CKD) is a progressive condition characterized by a permanent and
irreversible loss of renal function. In accordance to international guidelines, CKD clinical …

Introduction Chronic kidney disease is avery common and complex chronic disease.
Uncovering the pathological patterns of CKD on the molecular level of bio-fluids and tissue …

This paper discusses the use of biomarkers in clinical practice and biomedical research.
Biomarkers are measurable characteristics that can be used to indicate the presence or …

Prognosis, risk stratification and monitoring the effects of treatment are fundamental
elements in the decision-making process when implementing prevention strategies for …